Biomarkers of Infection-Associated Cancers (R21)

The summary for the Biomarkers of Infection-Associated Cancers (R21) Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.


	Federal Grant Title:	Biomarkers of Infection-Associated Cancers (R21)
	CFDA Number:	93.121
	CFDA Description:	Oral Diseases and Disorders Research
	Federal Agency Name:	National Institutes of Health
	Category of Funding Activity:	Education Health
	Category Explanation:	Information not provided
	Opportunity Category:	Discretionary
	Funding Opportunity Number:	PA-11-159
	Document Type:	Grants Notice
	Funding Instrument Type:	Grant
	Posted Date:	Mar 17, 2011
	Creation Date:	Mar 17, 2011
	Original Closing Date for Applications:	May 07, 2014
	Current Closing Date for Applications:	May 07, 2014
	Archive Date:	Jun 07, 2014
	Expected Number of Awards:	Information not provided
	Estimated Total Program Funding:	Information not provided
	Federal Grant Award Ceiling:	275,000
	Federal Grant Award Floor:	Information not provided
	Cost Sharing or Matching Requirement:	No

Applicants Eligible for this Grant: State governments
County governments
City or township governments
Special district governments
Independent school districts
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
For profit organizations other than small businesses
Small businesses
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Foreign (non-U.S.) components of U.S. Organizations are allowed.
Grant Description: This funding opportunity announcement (FOA), issued by the National Cancer Institute (NCI) and the National Institute of Dental and Craniofacial Research (NIDCR), of the National Institutes of Health (NIH), encourages the submission of Exploratory/Developmental Research Grant Award (R21) applications from institutions and organizations that propose to identify biomarkers for cancers where the etiology of the disease is attributed to infectious agents.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/pa-files/pa-11-159.html
Grant Announcement Contact: NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants: • Systems Developmental Biology for Understanding Embryonic Development and the Ontogeny of Structural...; • NIH Blueprint for Neuroscience Research Grand Challenge on the Transition from Acute to Chronic Neur...; • Effectiveness of Treatment for Oral Diseases in Medically Compromised Patients (R21); • Effectiveness of Treatment for Oral Diseases in Medically Compromised Patients (R01); • Collaborative Research on the Transition From Acute to Chronic Pain: New Models and Measures in Clin...; • EPIDEMIOLOGICAL AND BEHAVIORAL RESEARCH IN ORAL HEALTH; • METAGENOMIC ANALYSES OF THE ORAL MICROBIOME; • PHASE III CLINICAL TRIALS IN ORAL INFECTIOUS DISEASES; • NIDCR Exploratory and Developmental Grants in Clinical Research; • Multidisciplinary Research On Oral Manifestations Associated With HIV/AIDS